MEETINGS - The New FDA: Reinvention and Reform (US) May 1996:
This article was originally published in Clinica
Executive Summary
The New FDA: Reinvention and Reform takes place on May 16th- 17th, 1996, in Arlington, VA, US. It covers the major issues underlying the ongoing overhaul of the agency, and is sponsored by FDA Week. For more information, contact: IWP Conferences, PO Box 7167, Washington, DC 20044, US. Tel: +1 (703) 416 8505. Fax: +1 (703) 416 8543.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.